← FDA Drug Approvals (Drugs@FDA)

MITOMYCIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: FRESENIUS KABI USA · Approved 2024-04-05

Drug application

FDA Application #
ANDA211269
Application type
Abbreviated New Drug Application (Generic)
Brand name
MITOMYCIN
Generic name
Mitomycin
Active ingredients
MITOMYCIN
Dosage form
INJECTABLE
Route
INJECTION
Marketing status
Prescription
Sponsor
FRESENIUS KABI USA
First approval
2024-04-05

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown